ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter

April 5, 2019
Mick Jagger has undergone a TAVR procedure in New York and is now recovering.
April 3, 2019
In light of the recent Centers for Medicare and Medicaid Services recommendation for transcatheter aortic valve replacement (TAVR) volumes, this study looked at 113,662 TAVRs from the TVT registry from 2015 to 2017 and found that 30-day mortality was higher at low-volume TAVR hospitals or low-volume operators.
March 18, 2019
A number of interesting findings in early follow up of this randomized controlled trial on one type of transcatheter aortic valve against conventional surgery: the mechanics of the valve and the incidence of complete heart block, to name but a few. We await the longer follow up.
March 15, 2019
Drugs and Devices The US Food and Drug Administration (FDA) announced that the indications for the MitraClip™, made by Abbott, have been expanded to include secondary mitral regurgitation.
March 14, 2019
On Wednesday March 13, the ACC Quality Summit announced in New Orleans that beginning in mid-2019, hospitals performing transcatheter valve repair and replacement will be able to apply for the American College of Cardiology's new Transcatheter Valve Certification.
March 12, 2019
With the disruptive advancement of catheter-based technologies and minimally invasive techniques in structural heart disease, surgeons must obtain the necessary skills to continue to serve this large patient population. An emergency overhaul of current structural training must occur to ensure standardized training in structural heart disease.
March 8, 2019
Patient Care and General Interest The American Heart Association has released a scientific statement summarizing emerging knowledge about sensitization after heart transplant.
March 6, 2019
Takayuki and colleagues reviewed the outcome of mitral valve replacement after failed mitral valve repair with MitraClip in 25 patients. Perioperative mortality was 28%, and overall one-year survival was 53%. Risk factors for perioperative mortality included preoperative cardiogenic shock, septic shock, and liver failure.
February 27, 2019
Kofler and colleagues evaluated prospectively-measured psoas muscle area in more than 1,000 patients who underwent transcatheter aortic valve replacement at two centers. Indexed psoas area was independently associated with 30-day and follow-up mortality.

Pages